Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a score that predicts the risk of liver cancer. Published in the scientific journal ...

Chronic activation of the stress protein ATF6α promotes aggressive liver tumors by rewiring glucose metabolism and ...

Fibrolamellar carcinoma, a rare liver cancer affecting young adults, resists immunotherapy due to T-cell sequestration. Researchers found that combining AMD3100 with immune checkpoint inhibitors can ...

Endoplasmic reticulum (ER) stress and the unfolded protein response are often implicated in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD), from simple steatosis ...

A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

Explore the latest research on rare liver cancer and how a new drug may enable effective immunotherapy treatments.

The treatment plan for liver cancer can vary depending on the stage, size, and location of the tumor. Common options include surgery, ablation, cryotherapy, immunotherapy, and targeted drug therapy.

Researchers report that pairing two known medicines reduced liver fibrosis in mice, offering a possible path toward scar ...